INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "FORMULATIONS FOR ANTI-N3PGLU AMYLOID BETA ANTIBODIES"

GENEVA, Dec. 17 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/032381) for "FORMULATIONS FOR ANTI-N3pGlu AMYLOID BETA ANTIBODIES" on Jun 05, 2025. With publication no. WO/2025/255300, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MOULD, Ryan E. (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Indiana 46206-6288), WERNER, Andrew G. (c/o Eli Lilly and CompanyP.O. Box 6288Indianapolis, Idaho 46206-6288)

Abstract: The present disclosure is related to ...